Global X S&P Biotech ETF
CURE
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Why we’re neutral on this popular Aussie ETF
How index construction rules create a suboptimal portfolio.
etfs
Why ETFs win the tax battle over managed funds
These four structural advantages make ETFs a powerful tool for reducing tax drag.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,760.50 | 81.90 | 0.94% |
| CAC 40 | 7,743.92 | 17.72 | 0.23% |
| DAX 40 | 22,636.91 | 16.95 | -0.07% |
| Dow JONES (US) | 46,124.06 | 84.41 | -0.18% |
| FTSE 100 | 9,965.16 | 71.01 | 0.72% |
| HKSE | 25,063.71 | 681.24 | 2.79% |
| NASDAQ | 21,761.89 | 184.87 | -0.84% |
| Nikkei 225 | 53,857.78 | 1,605.50 | 3.07% |
| NZX 50 Index | 12,916.47 | 214.72 | 1.69% |
| S&P 500 | 6,556.37 | 24.63 | -0.37% |
| S&P/ASX 200 | 8,554.10 | 65.50 | 0.77% |
| SSE Composite Index | 3,881.28 | 0.00 | 0.00% |